Plasmablastic lymphoma: successful management with CHOP and lenalidomide in resource constraint settings

Ann Hematol. 2016 Oct;95(10):1715-7. doi: 10.1007/s00277-016-2732-9. Epub 2016 Jun 21.

Authors

Uday Yanamandra¹, Kamal Kant Sahu¹, Nidhi Jain¹, Gaurav Prakash¹, Uma Saikia², Pankaj Malhotra³

Affiliations

¹ Department of Internal Medicine (Clinical Hematology Division), PGIMER, Chandigarh, 160012, India.
² Department of Histopathology, P.G.I.M.E.R, Chandigarh. U.T, 160012, India.
³ Department of Internal Medicine (Clinical Hematology Division), PGIMER, Chandigarh, 160012, India. hematpgi@gmail.com.

PMID: 27324386
DOI: 10.1007/s00277-016-2732-9

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / economics
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cyclophosphamide / administration & dosage
Doxorubicin / administration & dosage
Female
Humans
Lenalidomide
Lymphoma, AIDS-Related / drug therapy*
Maxillary Sinus Neoplasms / drug therapy*
Plasmablastic Lymphoma / drug therapy*
Poverty
Prednisolone / administration & dosage
Remission Induction
Thalidomide / administration & dosage
Thalidomide / analogs & derivatives
Vincristine / administration & dosage

Substances

Thalidomide
Vincristine
Doxorubicin
Cyclophosphamide
Prednisolone
Lenalidomide

Supplementary concepts

VAP-cyclo protocol